Kerr Holbrook

Kerr Holbrook is a declared insider of Avanos Medical, Inc. (chief executive), with filings sourced from SEC (Form 4). In total, 23 filings cover trades dated from 4 March 2022 to 18 November 2025.

On the market, this insider has only sold: 5 sales, €241k in total. The rest of the record consists of 16 share grants and 2 option exercises. So far in 2025, the count stands at no purchases and 5 sales.

Most recently, on 19 November 2025, the filings show an open-market sale worth €2,900 in Avanos Medical, Inc. Typically, a trade is published a median of 1 day after it takes place. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.